Insulin Peglispro is Set to Become the Gold-Standard First-Line Therapy for Type 2

[Northerner]

Decision Resources Group finds that Eli Lilly’s insulin peglispro is set to become the clinical gold-standard in the treatment of patients with type 2 diabetes inadequately controlled with diet and exercise, when metformin is not a therapeutic option.

http://truebluetribune.com/insulin-...exercise-when-metformin-is-not-an-option/1741

http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5521